Jazz Pharmaceuticals(JAZZ) - 2024 Q3 - Earnings Call Transcript

Jazz Pharmaceuticals plc. (NASDAQ:JAZZ) Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ET Company Participants Andrea Flynn - Vice President and Head-Investor Relations Bruce Cozadd - Chairman and Chief Executive Officer Renée Galá - President and Chief Operating Officer Rob Iannone - Executive Vice President and Global Head-R&D Phil Johnson - Executive Vice President and Chief Financial Officer Conference Call Participants Jessica Fye - JPMorgan Jason Gerberry - Bank of America Marc Goodman - Le ...